NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 79 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q2 2024. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,956,529 | -18.4% | 3,827,577 | +2.6% | 0.00% | – |
| Q1 2024 | $10,971,503 | -5.8% | 3,731,804 | -4.2% | 0.00% | – |
| Q4 2023 | $11,641,976 | -1.5% | 3,893,637 | +4.1% | 0.00% | – |
| Q3 2023 | $11,814,763 | -15.3% | 3,738,849 | +3.7% | 0.00% | – |
| Q2 2023 | $13,948,734 | +52.5% | 3,604,324 | +9.2% | 0.00% | – |
| Q1 2023 | $9,144,867 | +51.8% | 3,301,396 | -1.3% | 0.00% | – |
| Q4 2022 | $6,023,382 | -11.5% | 3,346,323 | +4.3% | 0.00% | – |
| Q3 2022 | $6,804,000 | -22.3% | 3,209,494 | -1.4% | 0.00% | – |
| Q2 2022 | $8,758,000 | +67.3% | 3,256,032 | +170.0% | 0.00% | – |
| Q1 2022 | $5,234,000 | -19.3% | 1,205,986 | -3.7% | 0.00% | – |
| Q4 2021 | $6,485,000 | -14.0% | 1,251,848 | +1.9% | 0.00% | – |
| Q3 2021 | $7,542,000 | -25.1% | 1,228,288 | +23.2% | 0.00% | – |
| Q2 2021 | $10,068,000 | – | 996,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $14,089 | 15.03% |
| AH Capital Management, L.L.C. | 17,653,917 | $41,310,166 | 3.52% |
| Perceptive Advisors | 12,594,211 | $29,470,453 | 0.71% |
| Tikvah Management LLC | 726,895 | $1,700,934 | 0.56% |
| ArchPoint Investors | 614,271 | $1,437,394 | 0.54% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $4,680,000 | 0.51% |
| Cercano Management LLC | 7,172,985 | $16,784,785 | 0.45% |
| HILLMAN CO | 200,000 | $468,000 | 0.22% |
| Comprehensive Financial Management LLC | 2,207,620 | $5,165,831 | 0.18% |
| AMAZON COM INC | 1,457,055 | $3,409,509 | 0.14% |